CN Stock MarketDetailed Quotes

688513 Chengdu Easton Biopharmaceuticals

Watchlist
  • 36.71
  • +2.11+6.10%
Market Closed Sep 27 15:00 CST
6.48BMarket Cap26.83P/E (TTM)

Chengdu Easton Biopharmaceuticals Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Chengdu Easton Biopharmaceuticals Q2 2024 Earnings Date

Currency：CNYAug 20, 2024

Estimate
(YoY)		 Actual
(YoY)		 Vs Estimate
(% Chg)
Revenue
--
354.52M
--
+27.75%
Net Income
--
71.48M
--
+1.34%
Analyst Rating
Buy

Sep 28, 2024

Chengdu Easton Biopharmaceuticals Earnings Estimates

Revenue

EPS

EBIT

Revenue is based on 3 analyst forecasts. Estimate data is from S&P, and actual data is from Income Statement

Currency: CNY

Actual
Estimate
DatePeriodRevenue/EstimateEarnings Call
--2025/FY-- / 1.729B--
--2024/FY-- / 1.393B--
--2023/FY1.117B / 1.197B--
--2022/FY1.171B / 1.173B--
Mar 29, 20222021/FY1.023B / 1.090B--
DatePeriodRevenue/EstimateEarnings Call
--2025/FY-- / 1.729B--
--2024/FY-- / 1.393B--
--2023/FY1.117B / 1.197B--
--2022/FY1.171B / 1.173B--
Mar 29, 20222021/FY1.023B / 1.090B--

Unlock Free Earnings Estimates

Chengdu Easton Biopharmaceuticals Earnings Reports

  • Chengdu Easton Biopharmaceuticals: Half-year report for the year 2024.

    Aug 19 12:00 ET

  • Chengdu Easton Biopharmaceuticals: Summary of Half-Year Report in 2024.

    Aug 19 12:00 ET

  • Yuandong Biology: 2023 Annual Report Summary

    Apr 22 12:00 ET

  • Yuandong Biology: 2023 Annual Report

    Apr 22 12:00 ET

    • Read more

    Analysis

    Analyst Rating

    Updated: Sep 28, 2024

    Buy

    • Strong Buy

      20.00%

    • Buy

      80.00%

    • Hold

      0.00%

    • Underperform

      0.00%

    • Sell

      0.00%

    Price Target

    No Data

    Heat List
    CN
    Overall
    Symbol
    Latest Price
    % Chg

    No Data